Effects of clozapine on behavioral and metabolic traits relevant for schizophrenia in two mouse strains

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Psychopharmacology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1007/s00213-003-1553-4PMID 14615871
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats

  2005cited by this paper
• Recombinant congenic strains — A new tool for analyzing genetic traits determined by more than one gene

  2004cited by this paper
• Clozapine-induced weight gain predicts improvement in psychopathology.

  2003cited by this paper
• Studies on modulation of feeding behavior by atypical antipsychotics in female mice.

  2002cited by this paper
• Provisional Mapping of Quantitative Trait Loci Modulating the Acoustic Startle Response and Prepulse Inhibition of Acoustic Startle

  2002influential reference
• Antipsychotic-Induced Weight Gain and Therapeutic Response: A Differential Association

  2002cited by this paper
• Parental genetic contributions in the AXB and BXA recombinant inbred mouse strains

  2002cited by this paper
• Differential Effects of Direct and Indirect Dopamine Agonists on Prepulse Inhibition: A Study in D1 and D2 Receptor Knock-Out Mice

  2002cited by this paper
• Antipsychotic-associated weight gain and clinical outcome parameters.

  2001cited by this paper
• Recombinant congenic strains derived from A/J and C57BL/6J: a tool for genetic dissection of complex traits.

  2001cited by this paper
• The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics?

  2001cited by this paper
• Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

  2001cited by this paper
• Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity?

  2001cited by this paper
• Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

  2001cited by this paper
• Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.

  2001cited by this paper
• Clozapine and weight gain.

  2001cited by this paper
• Effects of acute versus chronic treatment with typical or atypical antipsychotics on d-amphetamine-induced sensorimotor gating deficits in rats

  2001cited by this paper
• “Early” and “Late” Effects of Sustained Haloperidol on Apomorphine- and Phencyclidine-induced Sensorimotor Gating Deficits

  2000cited by this paper
• Pharmacogenetic prediction of clozapine response.

  2000cited by this paper
• Analysing complex genetic traits with chromosome substitution strains

  2000cited by this paper
• Antipsychotic-induced weight gain: a comprehensive research synthesis.

  1999cited by this paper
• Differential effects of haloperidol and clozapine on ionotropic glutamate receptors in rats

  1999cited by this paper
• Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies

  1999cited by this paper
• A Test of the Predictive Validity of Animal Models of Schizophrenia Based on Phencyclidine and D-Amphetamine

  1998influential reference
• Birth insult increases amphetamine-induced behavioral responses in the adult rat.

  1998cited by this paper
• Serotonin Subtype 2 Receptor Genes and Clinical Response to Clozapine in Schizophrenia Patients

  1998cited by this paper
• D2-Like Dopamine Receptor Mediation of Social-Emotional Reactivity in a Mouse Model of Anxiety: Strain and Experience Effects

  1998cited by this paper
• Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia.

  1998influential reference
• Discrepant Findings of Clozapine Effects on Prepulse Inhibition of Startle: Is It the Route or the Rat?

  1998cited by this paper
• Efficacy and side‐effects of clozapine not associated with variation in the 5‐HT2C receptor

  1997cited by this paper
• Genetics, haloperidol-induced catalepsy and haloperidol-induced changes in acoustic startle and prepulse inhibition

  1997influential reference
• Potentiation of prepulse inhibition of the startle reflex in rats: pharmacological evaluation of the procedure as a model for detecting antipsychotic activity

  1997cited by this paper
• Inbred mouse strains differ in the regulation of startle and prepulse inhibition of the startle response.

  1997cited by this paper
• Inbred strain differences in prepulse inhibition of the mouse startle response

  1997influential reference
• The role of motor activity in diet-induced obesity in C57BL/6J mice.

  1996cited by this paper
• Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice.

  1995influential reference
• Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs

  1995cited by this paper
• Presynaptic dopamine-glutamate interactions in the nucleus accumbens regulate sensorimotor gating

  1995cited by this paper
• Prenatal stress in rats facilitates amphetamine-induced sensitization and induces long-lasting changes in dopamine receptors in the nucleus accumbens.

  1995cited by this paper
• Clozapine: efficacy and safety.

  1995cited by this paper
• Compliance with antipsychotic drug treatment: influence of side effects.

  1994cited by this paper
• Clozapine and weight gain.

  1994cited by this paper
• D1 and D2 dopamine receptor antagonists reverse prepulse inhibition deficits in an animal model of schizophrenia

  1994cited by this paper
• Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients.

  1994cited by this paper
• NBQX inhibits AMPA-induced locomotion after injection into the nucleus accumbens.

  1993cited by this paper
• Postpubertal Emergence of Hyperresponsiveness to Stress and to Amphetamine after Neonatal Excitotoxic Hippocampal Damage: A Potential Animal Model of Schizophrenia

  1993cited by this paper
• Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia.

  1993cited by this paper
• alpha-Amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonists in the nucleus accumbens and ventral pallidum decrease the hypermotility response to psychostimulant drugs.

  1992cited by this paper
• The recombinant congenic strains for analysis of multigenic traits: genetic composition

  1992cited by this paper
• Clozapine-induced weight gain: prevalence and clinical relevance.

  1992cited by this paper
• Prepulse inhibition as a screening test for potential antipsychotics

  1991cited by this paper
• Sensorimotor gating and schizophrenia. Human and animal model studies.

  1990cited by this paper
• Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain

  1990cited by this paper
• Startle response models of sensorimotor gating and habituation deficits in schizophrenia.

  1990influential reference
• Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats.

  1989cited by this paper
• Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

  1988cited by this paper
• Individual differences in responsiveness to single and repeated amphetamine administration: behavioral characteristics and neurochemical correlates.

  1987cited by this paper
• Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input.

  1980cited by this paper
• Sensitization to cocaine stimulation in mice

  1977cited by this paper
• Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats.

  1976cited by this paper
• Selective 60HDA-induced destruction of mesolimbic dopamine neurons: Abolition of psychostimulant-induced locomotor activity in rats

  1976cited by this paper

• The dosage-dependent effects of cevimeline in preventing clozapine-induced dyslipidaemia in female rats.

  2025cites this paper
• Chronic antipsychotic treatment exerts limited effects on the mania-like behavior of dopamine transporter knockdown mice.

  2021cites this paper
• ErbB signaling antagonist ameliorates behavioral deficit induced by phencyclidine (PCP) in mice, without affecting metabolic syndrome markers

  2017cites this paper
• Preclinical Effects of Antipsychotic Drugs.

  2016cites this paper
• A two-hit model of suicide-trait-related behaviors in the context of a schizophrenia-like phenotype: Distinct effects of lithium chloride and clozapine.

  2016cites this paper
• Effects of Chronic Exposure to the Antipsychotic Olanzapine on Metabolism and Hormones: Is There an Interaction with Dietary Fat Levels?

  2016cites this paper
• Psychosis (Schizophrenia Spectrum and Other Psychotic Disorders)

  2015cites this paper
• Animal models of eating disorders

  2012cites this paper
• Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism.

  2011cites this paper
• Behavioral effects of clozapine: involvement of trace amine pathways in C. elegans and M. musculus.

  2011cites this paper
• Preclinical models of antipsychotic drug-induced metabolic side effects.

  2010cites this paper
• A Murine Model of Atypical Antipsychotic‐Induced Weight Gain and Metabolic Dysregulation

  2010cites this paper
• Animal models of gene-environment interactions in schizophrenia.

  2009cites this paper
• Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.

  2008cites this paper
• Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities

  2007cites this paper
• Identification of Informative Strains and Provisional QTL Mapping of Amphetamine (AMPH)-Induced Locomotion in Recombinant Congenic Strains (RCS) of Mice

  2006cites this paper
• Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction.

  2006cites this paper
• Mechanistic connections between glucose/lipid disturbances and weight gain induced by antipsychotic drugs.

  2005cites this paper
• A parametric analysis of olanzapine-induced weight gain in female rats

  2005influential citation
• Antipsychotic‐induced weight gain

  2005cites this paper
• Comparative effects of the antipsychotics sulpiride and risperidone in female rats on energy balance, body composition, fat morphology and macronutrient selection.

  2004cites this paper
• Drug induced weight gain, an impediment to successful pharmacotherapy: focus on antipsychotics.

  2004cites this paper
• The Metabolic Syndrome During Atypical Antipsychotic Drug Treatment: Mechanisms and Management

  2004cites this paper
• Prepulse Inhibition Deficits in GAD65 Knockout Mice and the Effect of Antipsychotic Treatment

  2004cites this paper
• Pharmacogenomics and animal models of schizophrenia

  2003cites this paper